Elisa Kieback und Tcr - Info zur Person

(1 - 14 von 16

)

Loop | CAR-TCR Summit Europe 2018

www.frontiersin.org

... Adaptimmune, Representative to be confirmed, Cellectis, Dolores Schendel, CEO, Medigene, Elisa Kieback, CEO, T-Knife, Michael Leek, ...

Translation of TCRs to the clinic – MAGE-A1 TCR gene ...European Medicines Agency |

www.ema.europa.eu

Elisa Kieback. Vivian Scheuplein. Wolfgang Uckert. Matthias Leisegang. Kathrin Borgwald. Sabrina Horn. Kristin Retzlaff. Katerina Thiede. Dana Hoser.

A Method for the Generation of TCR Retrogenic Mice | SpringerLink

link.springer.com

Retrogenic mice provide a unique system for rapidly analyzing the function of genes in the hematopoietic system. Here, we provide a detailed protocol for the...

T-Knife – 1stOncology™: Cancer Intelligence Service

www.1stoncology.com

Elisa Kieback and Holger Specht. The Berlin-based Biotech company develops T cell receptors (TCRs) for T cell therapy of cancer which are ...

A Method for the Generation of TCR Retrogenic MiceSpringer Nature Experiments

experiments.springernature.com

Elisa Kieback et al., 2016, Immunity. Related articles. Based on techniques. Primary T-Cell Transduction to Study Follicular ...

A method for the generation of TCR retrogenic miceNational Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von E Kieback · · Zitiert von: 2 — Authors. Elisa Kieback , Ellen Hilgenberg, Simon Fillatreau. Affiliation. 1 Max Delbrueck Center for Molecular Medicine, Berlin, Germany.

Versant funds TCR therapy biotech T-knife's $78M+ Series ...Endpoints News

endpts.com

Elisa Kieback (T-knife). August 6, :00 AM EDTUpdated August 12, 05:44 AM. Financing · Startups. Versant funds TCR therapy biotech T-knife's $78M+ ...

Versant, RA Capital tee up T-knife to apply TCRs to solid ...FierceBiotech

www.fiercebiotech.com

... but you really use this natural selection that T cells undergo in an organism to select really specific receptors,” T-knife CEO Elisa Kieback said.

T-knife raises $78M in series A for TCR platform | BioWorld MedTech

www.bioworld.com

— Based on that work, T-knife has generated TCRs against more than 90 different tumor antigens, said Elisa Kieback, co-founder and CEO.

Optimal-affinity T cell receptors from humanized TCR mice. Elisa...

docplayer.net

... TCR mice Elisa Kieback, May Immunotherapy for Cancer TCR gene therapy Phase I/IIa T cell Cancer-specific receptor Cancer patient Cancer-specific T.

Uckert Lab | MDC Berlin

www.mdc-berlin.de

A long and winding road – a film with Thomas Blankenstein, Elisa Kieback, Mathias Leisegang, Antonio Pezzutto and Wolfgang Uckert. (with English subtitles) Team. Research. Antigen specificity of T cells is determined by their T cell receptor (TCR) and can be redirected by the transfer of TCRα/β genes. TCR gene-modified T cells can elicit ...